An Investigational Scan ([68Ga]DOTATATE-PET/MRI) for the Imaging of Liver Cancer
This phase I trial investigates whether [68Ga]DOTATATE-positron emission tomography (PET)/magnetic resonance imaging (MRI) can help measure levels of a protein called SSTR that may be present on liver tumor cells. [68Ga]DOTATATE is a radiopharmaceutical drug that is used clinically for people with other kinds of tumors. PET is a type of imaging test that uses a small amount of radioactive material injected into a vein to see how cells or tissues are functioning. MRI is a type of imaging test that uses radiofrequency waves and a strong magnetic field to provide detailed pictures of internal organs and tissues. PET/MRI is a new imaging technique that combines a PET scan and an MRI scan. Using [68Ga]DOTATATE-PET/MRI to measure SSTR levels in liver tumor cells may help researchers design a combined imaging and therapeutic study for liver cancer.